• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

老年医疗保险参保人群中心肌梗死或缺血性中风后的心血管事件及死亡情况。

Cardiovascular events and death after myocardial infarction or ischemic stroke in an older Medicare population.

作者信息

Li Suying, Peng Yi, Wang Xinyue, Qian Yi, Xiang Pin, Wade Sally W, Guo Haifeng, Lopez J Antonio G, Herzog Charles A, Handelsman Yehuda

机构信息

Hennepin Healthcare Research Institute, Chronic Disease Research Group, Minneapolis, Minnesota.

Amgen Inc., Thousand Oaks, California.

出版信息

Clin Cardiol. 2019 Mar;42(3):391-399. doi: 10.1002/clc.23160. Epub 2019 Feb 25.

DOI:10.1002/clc.23160
PMID:30697776
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6712383/
Abstract

BACKGROUND

Survivors of myocardial infarction (MI) or ischemic stroke (IS) are at high risk for subsequent cardiovascular events.

HYPOTHESIS

Older patients with prior MI or IS are at risk for recurrent cardiovascular events, and comorbidities such as diabetes may increase this risk.

METHODS

Two cohorts were studied in a retrospective Medicare 20% random sample-a 2008 cohort with up to 6 years of follow-up (MI, N = 26 460; IS, N = 17 566) and a 2012 cohort with 1 year of follow-up (MI, N = 26 548; IS, N = 17 728).

RESULTS

In older patients who survived an event of MI or IS (2012 cohort), 7.2% had a recurrent MI and 6.7% had a recurrent IS in the first year; 32% died. Accounting for multiple recurrent events (2012 cohort), the event rates per 100 patient-years were 11.6 and 10.2 for the MI and IS cohorts, respectively. Cumulative incidence of recurrence (2008 cohort) increased from 7.7% at 1 year to 14.3% at 6 years for recurrent MI and from 6.7% at 1 year to 13.4% at 6 years for recurrent IS. Comorbid diabetes (2012 cohort) was significantly associated (adjusted risk ratio) with MI recurrence (1.44) and risk of coronary revascularization (1.23) in the MI cohort and with IS recurrence (1.26) in the IS cohort.

CONCLUSION

In this older population with prior MI or IS, high rates of recurrent cardiovascular events and multiple recurrent events were observed. These findings highlight the need for aggressive intervention for secondary prevention and management of comorbidities in high-risk patients, particularly those with diabetes.

摘要

背景

心肌梗死(MI)或缺血性中风(IS)幸存者发生后续心血管事件的风险很高。

假设

既往有MI或IS的老年患者有发生心血管事件复发的风险,而糖尿病等合并症可能会增加这种风险。

方法

在一项回顾性医疗保险20%随机样本中研究了两个队列——一个2008年队列,随访时间长达6年(MI,N = 26460;IS,N = 17566),以及一个2012年队列,随访1年(MI,N = 26548;IS,N = 17728)。

结果

在经历过MI或IS事件后存活的老年患者(2012年队列)中,第一年有7.2%发生复发性MI,6.7%发生复发性IS;32%死亡。考虑到多次复发事件(2012年队列),MI队列和IS队列每100患者年的事件发生率分别为11.6和10.2。复发的累积发生率(2008年队列),复发性MI从1年时的7.7%增加到6年时的14.3%,复发性IS从1年时的6.7%增加到6年时的13.4%。合并糖尿病(2012年队列)与MI队列中的MI复发(调整风险比为1.44)和冠状动脉血运重建风险(1.23)以及IS队列中的IS复发(1.26)显著相关。

结论

在这个既往有MI或IS的老年人群中,观察到心血管事件复发率和多次复发事件发生率很高。这些发现凸显了对高危患者,尤其是糖尿病患者进行积极干预以进行二级预防和合并症管理的必要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8de8/6712383/0915486046c6/CLC-42-391-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8de8/6712383/d49064066fb3/CLC-42-391-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8de8/6712383/0915486046c6/CLC-42-391-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8de8/6712383/d49064066fb3/CLC-42-391-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8de8/6712383/0915486046c6/CLC-42-391-g002.jpg

相似文献

1
Cardiovascular events and death after myocardial infarction or ischemic stroke in an older Medicare population.老年医疗保险参保人群中心肌梗死或缺血性中风后的心血管事件及死亡情况。
Clin Cardiol. 2019 Mar;42(3):391-399. doi: 10.1002/clc.23160. Epub 2019 Feb 25.
2
Incidence, timing, and type of first and recurrent ischemic events in patients with and without peripheral artery disease after an acute coronary syndrome.急性冠状动脉综合征后伴或不伴外周动脉疾病患者首发和复发性缺血事件的发生率、时间和类型。
Am Heart J. 2018 Jul;201:25-32. doi: 10.1016/j.ahj.2018.03.013. Epub 2018 Mar 28.
3
Effect of prompt revascularization on outcomes in diabetic patients with stable ischemic heart disease and previous myocardial infarction in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial.在“旁路血管成形术血运重建研究2糖尿病(BARI 2D)试验”中,早期血运重建对患有稳定型缺血性心脏病且既往有心肌梗死的糖尿病患者预后的影响。
Coron Artery Dis. 2017 Jun;28(4):301-306. doi: 10.1097/MCA.0000000000000492.
4
Cardiovascular outcomes among elderly patients with heart failure and coronary artery disease and without atrial fibrillation: a retrospective cohort study.老年心力衰竭合并冠心病且无房颤患者的心血管结局:一项回顾性队列研究。
BMC Cardiovasc Disord. 2019 Jan 15;19(1):19. doi: 10.1186/s12872-018-0991-1.
5
Predictors of subsequent myocardial infarction, stroke, and death in stable post-myocardial infarction patients: A nationwide cohort study.稳定性心肌梗死后患者发生后续心肌梗死、卒中和死亡的预测因素:一项全国性队列研究。
Eur Heart J Acute Cardiovasc Care. 2019 Oct;8(7):634-642. doi: 10.1177/2048872617730037. Epub 2017 Sep 12.
6
Long-Term Risk of Myocardial Infarction Compared to Recurrent Stroke After Transient Ischemic Attack and Ischemic Stroke: Systematic Review and Meta-Analysis.短暂性脑缺血发作和缺血性脑卒中后心肌梗死与复发性卒中的长期风险比较:系统评价和荟萃分析。
J Am Heart Assoc. 2018 Jan 18;7(2):e007267. doi: 10.1161/JAHA.117.007267.
7
Risk for recurrent cardiovascular disease events among patients with diabetes and chronic kidney disease.糖尿病合并慢性肾脏病患者的心血管疾病事件再发风险。
Cardiovasc Diabetol. 2021 Mar 1;20(1):58. doi: 10.1186/s12933-021-01247-0.
8
Recurrent myocardial infarction after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.ST 段抬高型心肌梗死患者行直接经皮冠状动脉介入治疗后复发心肌梗死。
Am J Cardiol. 2014 Jan 15;113(2):229-35. doi: 10.1016/j.amjcard.2013.08.039. Epub 2013 Oct 3.
9
Long-term cardiovascular risk and costs for myocardial infarction survivors in a US commercially insured population.美国商业保险人群中心肌梗死幸存者的长期心血管风险和成本
Curr Med Res Opin. 2016;32(4):703-11. doi: 10.1185/03007995.2015.1136607. Epub 2016 Feb 10.
10
International Validation of the Thrombolysis in Myocardial Infarction (TIMI) Risk Score for Secondary Prevention in Post-MI Patients: A Collaborative Analysis of the Chronic Kidney Disease Prognosis Consortium and the Risk Validation Scientific Committee.国际验证心肌梗死后血栓溶解治疗(TIMI)风险评分在 MI 后患者二级预防中的应用:慢性肾脏病预后联盟和风险验证科学委员会的协作分析。
J Am Heart Assoc. 2018 Jul 7;7(14):e008426. doi: 10.1161/JAHA.117.008426.

引用本文的文献

1
Immunization and cardiovascular disease in Latin America. The CorVacc study: rationale and design.拉丁美洲的免疫接种与心血管疾病。CorVacc研究:原理与设计。
Arch Cardiol Mex. 2025;95(3):144-152. doi: 10.24875/ACM.24000239.
2
High-Tyrosol/Hydroxytyrosol Extra Virgin Olive Oil Enhances Antioxidant Activity in Elderly Post-Myocardial Infarction Patients.高酪醇/羟基酪醇特级初榨橄榄油增强老年心肌梗死后患者的抗氧化活性。
Antioxidants (Basel). 2025 Jul 16;14(7):867. doi: 10.3390/antiox14070867.
3
Cost-Effectiveness of the CADScor System in Low-Risk Patients Presenting to the Emergency Department with Chest Pain.

本文引用的文献

1
Using big data from health records from four countries to evaluate chronic disease outcomes: a study in 114 364 survivors of myocardial infarction.利用来自四个国家健康记录的大数据评估慢性病结局:一项针对114364名心肌梗死幸存者的研究。
Eur Heart J Qual Care Clin Outcomes. 2016 Jul 1;2(3):172-183. doi: 10.1093/ehjqcco/qcw004.
2
2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association.2018 急性缺血性脑卒中患者早期管理指南:美国心脏协会/美国卒中协会医疗保健专业人员指南。
Stroke. 2018 Mar;49(3):e46-e110. doi: 10.1161/STR.0000000000000158. Epub 2018 Jan 24.
3
CADScor系统在因胸痛就诊于急诊科的低风险患者中的成本效益分析
Pharmacoecon Open. 2025 Jun 23. doi: 10.1007/s41669-025-00590-2.
4
FOS as a biomarker for myocardial infarction treatment with Deng's Yangxin Decoction: a systems biology-based analysis.以FOS作为邓氏养心汤治疗心肌梗死生物标志物的基于系统生物学的分析
Front Cardiovasc Med. 2025 May 30;12:1488684. doi: 10.3389/fcvm.2025.1488684. eCollection 2025.
5
Incorporating the STOP-BANG questionnaire improves prediction of cardiovascular events during hospitalization after myocardial infarction.纳入 STOP-BANG 问卷可改善心肌梗死后住院期间心血管事件的预测。
Sci Rep. 2025 May 31;15(1):19180. doi: 10.1038/s41598-025-03882-z.
6
The Holy Grail of cardiology?心脏病学的圣杯?
Exp Physiol. 2025 Aug;110(8):1017-1022. doi: 10.1113/EP092560. Epub 2025 Feb 13.
7
Cardioprotective Effects of Adiponectin-Stimulated Autophagy.脂联素刺激自噬的心脏保护作用
J Lipid Atheroscler. 2025 Jan;14(1):40-53. doi: 10.12997/jla.2025.14.1.40. Epub 2024 Nov 7.
8
Uric acid is associated with increased risk of myocardial infarction: results from NHANES 2009-2018 and bidirectional two-sample Mendelian randomization analysis.尿酸与心肌梗死风险增加相关:来自 NHANES 2009-2018 年的结果和双向两样本 Mendelian 随机化分析。
Front Endocrinol (Lausanne). 2024 Oct 18;15:1424070. doi: 10.3389/fendo.2024.1424070. eCollection 2024.
9
Cost-Utility Analysis of Low-Dose Pioglitazone in a Population With Prediabetes and a History of Stroke or Transient Ischemic Attack.吡格列酮治疗有糖尿病前期病史及卒中和短暂性脑缺血发作史人群的成本效用分析。
J Am Heart Assoc. 2024 Nov 5;13(21):e034531. doi: 10.1161/JAHA.123.034531. Epub 2024 Oct 25.
10
A multi-site mixed-method evaluation of 'Cardiac College for Women' implementation: perspectives of cardiac rehabilitation patients and providers.“女性心脏学院”实施情况的多地点混合方法评估:心脏康复患者和提供者的观点
Front Cardiovasc Med. 2024 Oct 8;11:1430268. doi: 10.3389/fcvm.2024.1430268. eCollection 2024.
Statin-prescribing trends for primary and secondary prevention of cardiovascular disease.
他汀类药物用于心血管疾病一级和二级预防的处方趋势。
Can Fam Physician. 2017 Nov;63(11):e495-e503. Epub 2017 Nov 14.
4
Real-world cardiovascular disease burden in patients with atherosclerotic cardiovascular disease: a comprehensive systematic literature review.动脉粥样硬化性心血管疾病患者的真实世界心血管疾病负担:一项全面的系统文献综述。
Curr Med Res Opin. 2018 Mar;34(3):459-473. doi: 10.1080/03007995.2017.1401529. Epub 2018 Jan 4.
5
Cardiovascular safety and efficacy of the PCSK9 inhibitor evolocumab in patients with and without diabetes and the effect of evolocumab on glycaemia and risk of new-onset diabetes: a prespecified analysis of the FOURIER randomised controlled trial.在有和没有糖尿病的患者中,PCSK9 抑制剂依洛尤单抗的心血管安全性和疗效,以及依洛尤单抗对血糖和新发糖尿病风险的影响: FOURIER 随机对照试验的预先指定分析。
Lancet Diabetes Endocrinol. 2017 Dec;5(12):941-950. doi: 10.1016/S2213-8587(17)30313-3. Epub 2017 Sep 15.
6
Differential occurrence, profile, and impact of first recurrent cardiovascular events after an acute coronary syndrome.急性冠状动脉综合征后首次复发性心血管事件的差异发生率、特征及影响
Am Heart J. 2017 May;187:194-203. doi: 10.1016/j.ahj.2017.01.016. Epub 2017 Feb 21.
7
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIA AND PREVENTION OF CARDIOVASCULAR DISEASE.美国临床内分泌医师协会和美国内分泌学会血脂异常管理与心血管疾病预防指南
Endocr Pract. 2017 Apr;23(Suppl 2):1-87. doi: 10.4158/EP171764.APPGL.
8
Adherence to High-Intensity Statins Following a Myocardial Infarction Hospitalization Among Medicare Beneficiaries.医疗保险受益人群心肌梗死后高强度他汀类药物的依从性。
JAMA Cardiol. 2017 Aug 1;2(8):890-895. doi: 10.1001/jamacardio.2017.0911.
9
Mortality and morbidity trends after the first year in survivors of acute myocardial infarction: a systematic review.急性心肌梗死幸存者第一年之后的死亡率和发病率趋势:一项系统评价
BMC Cardiovasc Disord. 2017 Feb 7;17(1):53. doi: 10.1186/s12872-017-0482-9.
10
Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association.《2017年心脏病和中风统计数据更新:美国心脏协会报告》
Circulation. 2017 Mar 7;135(10):e146-e603. doi: 10.1161/CIR.0000000000000485. Epub 2017 Jan 25.